The genetic programs that maintain hematopoiesis during steady state in physiologic conditions are different from those activated during stress. Here, we show that hematopoietic stem cells (HSCs) with deficiencies in components of the alternative NFjB pathway (the NFjB inducing kinase, NIK, and the downstream molecule NFjB2) had a defect in response to stressors such as supraphysiological doses of cytokines, chemotherapy, and hematopoietic transplantation. NIK-deficient mice had peripheral blood and bone marrow leukocyte numbers within normal ranges (except for the already reported defects in B-cell maturation); however, HSCs showed significantly slower expansion capacity in in vitro cultures compared to wild-type HSCs. This was due to a delayed cell cycle and increased apoptosis. In vivo experiments showed that NIKdeficient HSCs did not recover at the same pace as controls when challenged with myeloablative chemotherapy. Finally, NIK-deficient HSCs showed a significantly decreased competitive repopulation capacity in vivo. Using HSCs from mice deficient in one of two downstream targets of NIK, that is, either NFjB2 or c-Rel, only NFjB2 deficiency recapitulated the defects detected with NIK-deficient HSCs. Our results underscore the role of NIK and the alternative NFjB pathway for the recovery of normal levels of hematopoiesis after stress. STEM CELLS 2015;33:2825-2837
INTRODUCTION
Under homeostatic conditions, the continuous production of billions of erythrocytes, leukocytes, and platelets (PLT), and the maintenance of the immune system rely in the self-renewal and multipotential capacities of hematopoietic stem cells (HSCs). A fine regulation between self-renewal and differentiation exists. Extrinsic factors provided by the microenvironment (adhesion molecules, cytokines, and chemokines) [1, 2] as well as intrinsic factors such as transcription factors members of the Hox family [3] , Bmi-1 [4] , cell cycle regulators p21, p27 [5, 6] , p18 [7] , or the oxidative stress pathway [8] [9] [10] have been reported to modulate HSC activities during physiological conditions. HSCs are also responsible for regenerating the hematopoietic system after several pathological and clinical situations that induce the activation of normally quiescent HSCs, and the proliferation and differentiation that ensue restores hematopoietic homeostasis [11, 12] . Less is known about the factors or mechanisms that control the response of HSCs to stressors. Deficiencies in molecular pathways involved in the response of HSCs to stress could interfere with the recovery after chemotherapy, hinder the engraftment after HSC transplantation, and also cause aplastic anemia.
NFjB is a family of transcription factors composed of homo and heterodimers of proteins that include p105/50 (NFjB1), p100/p52 (NFjB2), p65 (Rel-A), Rel-B, and c-Rel. NFjB stimulates the expression of a panel of survival/antiapoptosis proteins and also modifies the expression of target genes of cell growth, proliferation, differentiation, immune response, and inflammation [13] [14] [15] . These proteins are located in the cytoplasm in an inactive state, but are released and translocated to the nucleus upon activation. Two main pathways have been described for NFjB activation. In the canonical pathway, IjB kinases (IKKa, IKKb, and IKKc) phosphorylate IjB (particularly IjBa) molecules in response to different activators (viruses, inflammatory cytokines, mitogens, and T-cell receptor signaling). IjB is also ubiquitinated and then degraded by the proteasome, releasing the NFjB transcription factors. Members of the family of TNF receptors (LTbR, CD40, BAFFR, and RANK) and some viruses (Epstein-Barr virus and human immunodeficiency virus) can activate NFjB through an alternative (noncanonical) pathway. A central component of the noncanonical pathway is the NFjB inducing kinase (NIK), a MAP kinase kinase kinase member [16, 17] . NIK was described as a serine/threonine kinase that interacted with TRAF2, activating NFjB [18] . NIK acts through IKKa [19] and stimulates the phosphorylation, ubiquitination, and processing of p100 [18, 20] . The processing of p100 generates p52 and induces nuclear translocation of RelB/p52 heterodimers. NIK can also activate c-rel transactivation activity [21] .
Many groups have studied the role of NIK and the noncanonical pathway in the immune system. Inactivation or deficits in this pathway negatively affected the numbers and functions of B and T lymphocytes [22, 23] , and the structure of lymphoid organs [24] . Deficiencies in NIK activity resulted in impaired models of immune diseases such as graft versus host disease (GVHD) [21, 25] , experimental autoimmune encephalomyelitis (EAE) [26] , and arthritis [27] . Conversely, deregulated (constitutively activated) activation of the noncanonical NFjB pathway has been described in human diseases and contributes to the development of lymphoid malignancies [28] [29] [30] [31] , multiple myeloma [32] , and solid tumors [33] [34] [35] [36] . However, there are few studies on the role of NIK or the alternative pathway in HSCs function [37] . We previously described that GVHD did not occur when donor cells had an inactive NIK protein, due to increased apoptosis of T lymphocytes [21] . In this article, we have focused on the role of NIK in another major item in stem cell transplantation, that is, hematopoietic regeneration. We found that NIK deficiency confers a proliferative disadvantage and increased apoptosis in HSCs in the transplantation context, and confirmed these findings in different stressful conditions. All these defects were recapitulated using HSCs from an NFjB2-deficient mouse. Our results underscore a role for NIK and the alternative NFjB pathway in HSCs function after stressful situations. chimeric total BM cells were transplanted into lethally irradiated P3B female in serial transplant assays. Engraftment kinetics was analyzed at PB 1 and 2 months after secondary transplants. DNA was extracted from PB using DNAeasy Mini Kit (Qiagen, Hilden, Germany. https://www.qiagen.com), and exogenous reconstitution was determined by Q-PCR analyses, conducted in a 7500 Real-Time PCR System (Life Technologies, Applied Biosystem. Foster City, CA, www.lifetechnologies.com), and using primers and a probe for the SRY gene, specific to the Y chromosome as described before [40] .
MATERIALS AND METHODS

Mice and Irradiation Procedures
Homing Assay
A total of 5 3 10 6 BM cells from NIK aly/aly or WT were transplanted into lethally irradiated female P3B mice. After 16 hours, mice were sacrificed and CD45.2 engraftment was analyzed by flow cytometry of BM. 
BM Transplantation and 5-Fluorouracil Treatment
Western Blot Analysis
Western blot analyses were performed using whole cell lysate prepared from BM from 5-FU treated mice prepared with RIPA buffer (Sigma Chemicals, St. Louis, MO, http://www.sigmaaldrich. com/). Samples were separated on 10% polyacrylamide gels and transferred to nitrocellulose membranes for antibody detection. 
In Vitro Cultures
Clonogenic assays were done to determine granulocytemacrophage colony-forming units (CFU). Total BM cells were seeded in MethoCult GF M3534 culture media (Stem Cell Technologies, Vancouver, BC, Canada, http://www.stemcell. com/) and cultured at 378C in 5% CO 2 and fully humidified air. Colonies were scored after 7 days of culture. 10 5 Lin2 purified cells or 10 4 freshly sorted LSK cells from NIK aly/aly and WT mice BM were cultured in Iscove's Modified Dulbecco's Medium (IMDM) (Gibco Laboratories, Grand Island, NY, www.lifetechnologies.com) medium with 20% Fetal Bovine Serum (FBS) (Lonza, Basel, Switzerland, http://www.lonza.com), Glutamine/Pen-strepto (Gibco Laboratories, Grand Island, NY, www.lifetechnologies.com), 100 ng/ml hIL11 (Miltenyi Biotech, Bergisch Gladbach, Germany, http://www.miltenyibiotec.com/), and 100 ng/ml mSCF (Miltenyi Biotech, Bergisch Gladbach, Germany, http://www.miltenyibiotec.com/) [41] . Total cells were counted weekly, and diluted to the initial concentration.
For proliferation assay, Lin2 cells were stained with Carboxyfluorescein succinimidyl ester (CFSE) (Molecular Probes. Eugene, OR, www.lifetechnologies.com) following manufacturer's instructions. Labeled cells were cultured in supplemented medium and CFSE dilution was analyzed daily by flow cytometry. Apoptosis was also analyzed in these cultures as explained before.
Gene Expression Microarray
Total RNA was isolated from freshly sorted LSK population of WT and NIK aly/aly mice using TRIzol reagent (Invitrogen, Carlsbad, California, www.lifetechnologies.com) and its quality checked in the Agilent 2100 Bioanalyzer platform (Agilent Technologies, Santa Clara, CA, http://www.chem.agilent.com/). To produce Cy3-labeled cRNA, the RNA samples were amplified (using a linear T7-based amplification step) and labeled using the Agilent Low Input Quick-Amp Labeling kit (Agilent Technologies, Santa Clara, CA, http://www.chem.agilent.com/). The hybridization procedure was performed according to the Agilent 60-mer oligo microarray processing protocol using the Agilent Gene Expression Kit to a Agilent Whole Mouse Genome Oligo Microarrays 8x60K. We analyzed three samples as independent triplicates for NIK aly/aly and for WT. Each LSK sample was the pool of three to four mice. Microarray analysis was performed with Agilent Whole Mouse Genome Oligo Microarrays. Student's test was applied on the normalized log 2-ratio intensity data to distinguish expression differences between WT and NIK aly/aly sample groups. Candidate genes were required to have an expression difference of at least 1.5-fold, with p-value less than or equal to .05. Search for transcription factor binding sites was performed with MatInspector (Genomatix, M€ unchen, Germany, www.genomatix.de). Pathway analysis was carried out on the Ingenuity Pathway Analysis (IPA) platform (Qiagen, Hilden, Germany, https://www.qiagen. com). Microarray data are available under GSE63702 at http:// www.ncbi.nlm.nih.gov/geo/.
Statistics
All statistical analyses were performed using Stata/IC 11.0 (StataCorp LP, College Station, TX, http://www.stata.com/). The nonparametric Wilcoxon rank-sum test was used to compare quantitative variables. Results were considered statistically significant with p < .05. All graphics present the mean 6 SE.
RESULTS
Hematopoiesis of NIK-Deficient aly/aly Mice Is Normal Under Steady-State Conditions
Basal hematopoiesis was studied in PB and BM of adult NIK aly/aly and WT mice. Apart from the already reported defects in B-cell maturation [22] [23] [24] , NIK aly/aly mice did not present major disturbances in PB leukocyte numbers. The cellularity of white blood cells (WBC), PLT, and red blood cells was not significantly different comparing mutant and wildtype mice. Cellularity and lineages in BM were also within normal ranges (Supporting Information Fig. S1A ).
To study the committed compartment, we next performed clonogenic assays from BM cells. NIK aly/aly mice presented numbers of CFU colonies that were not significantly different than those of controls (Fig. 1A) .
To study the stem cell compartment, we analyzed BM using multiparametric flow cytometry. Several populations containing hematopoietic stem and progenitor cells, such as LSK [42, 43] , LT-HSC (LSK CD135-CD1501CD342) [44] , ST-HSC (LSK CD1352CD1501CD341), MPP (LSKCD1351), or the SLAM (Lin neg CD1501CD482) HSCs [45, 46] were studied ( Fig. 1B and Supporting Information Fig. S1B) . Although values tended to be lower in LSK, LT-HSC, and SLAM populations (not in ST-HSC and MPP), there were no statistically significant differences in any populations between NIK aly/aly mice and those in WT. Proportions of Sca1 1 cells in NIK aly/aly BM were lower than in WT, reflecting the deficit in B-cell progenitors [47] . In addition to the HSC phenotype, we found similar distribution of cells in the G 0 , G 1 , and S/G 2 /M phases of the cell cycle in LSK and SLAM HSCs from NIK aly/aly BM compared with control mice, in the steady state (Fig. 1C ). All the above indicated that NIK inactivation (aly mutation) did not affect mature PB lineages (except for B-cells), progenitor compartment, absolute numbers and quiescence of HSC subpopulations in steady-state hematopoiesis.
NIK aly/aly Mice Show a Defect in Reconstitution Ability
We next studied the effects of NIK deficiency in situations of stress. Since recovery of the hematopoietic system after BM transplantation is the most stressful condition for HSCs, we performed a serial transplantation assay using cells from NIK aly/aly and WT BM cells. We first transplanted CD45.2 cells into lethally irradiated P3B mice (10 7 cells per recipient animal). NIK aly/aly and WT HSCs similarly and completely reconstituted the hematopoiesis of primary recipients in a WT environment ( Fig. 2A) . Two months after this first transplant, CD45.2 donor-derived cells were recovered from BM (with similar engraftment values than PB, data not shown), mixed at a 3:1 ratio with fresh competitor CD45.1 cells, and transplanted into lethally irradiated mice (P3D2F1, CD45.1/CD45.2) (Fig. 2A) . Short-and long-term hematopoiesis were analyzed monthly in PB. We found that NIK aly/aly PB chimerism was significantly lower than WT at 1 month post-transplant (mpt) ( Fig. 2A and Supporting Information Fig. S2A) , and decreased over time in secondary recipients ( Fig. 2A and Supporting Information Fig. S2A ). These data indicate that NIK deficiency promotes HSC depletion during serial transplantation.
To further evaluate the self-renewal capacity of NIK (Fig. 2B) . The values of NIK aly/aly CD45.2 1 were significantly lower than the WT at 5 mpt, in PB (Fig. 2B) and BM (Fig. 2C ). Further analysis of BM in recipient mice showed that NIK deficiency resulted in a significant decrease of absolute numbers of LSK 5 mpt (Fig. 2D) , suggesting that NIK
aly/aly
HSCs have diminished self-renewal ability.
We also analyzed lineage differentiation in PB of recipients, and found that both NIK aly/aly and WT HSCs repopulated a multilineage hematopoiesis upon transplantation (Supporting Information Fig. S2B ). A significant difference was observed in the contribution of myeloid versus B lymphocytes compartment in the reconstitution of NIK aly/aly and WT hematopoiesis (Supporting Information Fig. S2B) .
To further confirm a defect in reconstitution ability, chimeric BM cells were retransplanted into secondary recipient mice 5 mpt. The low engraftment values of CD45.2 NIK aly/aly were maintained at minimal percentages (Fig. 2E) . The analyses of PB of secondary recipients confirmed the repopulation capacity defect of the HSCs with a NIK inactivated protein.
NIK
aly/aly HSCs Show a Intact Homing Ability
To rule out whether the defect in reconstitution ability showed by NIK aly/aly HSC was secondary to a defect in homing, we transplanted total BM from NIK aly/aly mice or WT into lethally irradiated P3B mice and analyzed marrow and spleen 16 hours after transplant. The absolute numbers of donor LSK CD45.2 1 cells were similar comparing NIK aly/aly versus WT (Fig. 3) . This data suggested that NIK activity is dispensable for the efficient homing of HSCs in the BM. Thus, our results clearly indicated a defective repopulation ability of NIK aly/aly HSCs, not due to a defect in their homing ability.
aly/aly HSCs Show a Delayed Hematopoietic Recovery After Myeloablative Chemotherapy
To further evaluate the influence of NIK aly/aly mutation on the reconstitution capacity of HSCs under hematopoietic stress, we analyzed HSC at different points following myeloablative chemotherapy. 5-FU is a known myeloablative agent used in cancer therapy. In the hematopoietic system, 5-FU kills cycling cells, including progenitors, and induces the cycling of more primitive HSCs. To confirm that 5-FU therapy activated the NFkB alternative pathway in hematopoiesis, we treated NIK aly/aly and WT mice with 5-FU and did Western blot on extracts from BM cells. A significant reduction in the expression of p52 was found in aly/aly mice, while p100 was detected at comparable levels compared to control [24] (Supporting Information Fig. S3 ). To exclude the potential effects of 5-FU on nonhematopoietic tissues, we first transplanted NIK aly/aly or WT BM cells into lethally irradiated CD45.1 mice. Two months later, we confirmed total engraftment of donor cells [48] . A single dose of 5-FU was injected and WBC counts were obtained at 4, 10, 15, and 32 days post-treatment (dpt). PB counts in WT STEM CELLS chimera at 4 dpt were slightly lower (but not significant) compared to those in NIK aly/aly chimera (Fig. 4A) . The recovery of the PB leukopenia was delayed in NIK aly/aly chimeric mice compared to controls (at 15 and 30 dpt) (Fig. 4A ), indicating that NIK plays an essential role in HSC proliferation after a stressor such as myelotoxic chemotherapy.
The absolute numbers of LSK cells in BM were no different between NIK aly/aly and WT mice. Significantly higher percentages of LSK NIK aly/aly were detected 6 days posttreatment compared to those at day 2 (Fig. 4B) . To further study the response of HSC to 5-FU, we performed apoptosis and cell cycle analysis of LSK at days 2 and 6. Proportions of quiescent cells (G0) diminished over the 6 days period, and were always significantly higher in NIK aly/aly versus WT LSK. On the contrary, percentages of cycling LSK were significantly lower among NIK aly/aly versus WT at days 2 (S phase) and 6 (G2/M). The analysis of apoptosis showed a significant decreased in the proportion of living cells at days 2 and 6 among NIK aly/aly LSK cells (Fig. 4D ). These data suggested that NIK deficiency compromised the HSC reconstitution ability after myeloablative chemotherapy, due to a delayed cell cycle progression and an elevated apoptosis rate. Together with the competitive repopulation experiments, these results show that HSCs need a fully active NIK protein to cope with stressful conditions in vivo.
Aly/aly Progenitor Cells Have a Defective Expansion Capacity Due to an Impaired Proliferation and Increased Apoptosis During Stress
We also studied the effect of supraphysiological levels of cytokines that drive hematopoietic cells into expansion in vitro. We set up in vitro experiments to assess the proliferative capacity of hematopoietic cells. Liquid cultures of Lin2 cells from NIK aly/aly or WT mice were maintained during 14 days. Total numbers of cells were determined weekly and we observed a significant impairment in the expansion capacity of Lin2 cells from NIK aly/aly versus WT mice (Fig. 5A) . These results were confirmed with a more homogeneous starting HSC population. Ten thousand sorted LSK cells were placed in liquid cultures and cells were counted weekly. After 14 days, a significant decrease in the fold expansion was observed in NIK aly/aly HSC compared with WT HSC cells (Fig. 5B) . These data suggested that NIK aly/aly have a defective proliferative capacity in the HSC compartment.
One possible explanation for this may be a defective proliferation of NIK aly/aly hematopoietic cells compared to controls. To test this hypothesis, Lin 2 BM cells were labeled with CFSE and dye dilution was analyzed as a means to evaluate rounds of cell division. A marked delayed in the CFSE dilution was observed in NIK aly/aly cells compared with WT ones. At day 2, approximately more than 70% of WT cells had undergone three or more cell divisions, while only 18% NIK aly/aly cells had reached three rounds of cell division (Fig. 5C ). This result indicated that the expansion defect in Lin2 cells from NIK aly/aly mice was due in part to a defect in the proliferation capacity. This result is consistent with the delayed recovery observed after 5-FU treatment in vivo by accumulation on G0 phase and with the severe proliferative disadvantage observed in competitive repopulating assays.
An increased rate of apoptosis of proliferating NIK aly/aly hematopoietic cells could also account for the differences in the final total numbers. We analyzed cell viability to rule out that an increased apoptotic ratio could explain the expansion defect after exposure to cytokines. We found that NIK aly/aly and WT hematopoietic cells differed in the proportions of apoptotic cells in culture. Both at days 2 and 5 after culture initiation, NIK aly/aly BM cells presented higher rates of apoptosis compared with WT hematopoietic cells (Fig. 5C ). The differences at day 2 were statistically significant. Similarly as 5-FU treated BM, these results indicated that NIK plays an important role for maintaining viability of hematopoietic cells after a proliferative stress.
The NIK-NFjB2 Pathway Controls HSCs During Stress Hematopoiesis
Since NIK may signal through p100/p52 [18] and cRel [49] , we further investigated which of those pathways were involved in the deficiencies found with the NIK aly/aly HSCs. For this, we used NFjB2 2/2 [38] and cRel 2/2 [39] mice and repeated the experiments discussed above. The results obtained when using NFjB2 2/2 HSCs were comparable to those described with NIK aly/aly cells in similar experimental conditions. In competitive repopulation assays, the levels of chimerism (donor CD45.2 cells) in PB of mice transplanted with cRel 2/2 HSCs were not inferior to those of mice transplanted with WT HSCs (Fig. 6A) , while mice transplanted with NFjB2 2/2 HSCs showed significantly lower levels than control (Fig. 6B) . Furthermore, the levels of NFjB2 2/2 engraftment decreased from 1 mpt to the end of the experiment (25% at 1 mpt to 10% at 5 mpt) (Fig.  6B) . The differentiation into B and T lymphoid and myeloid lineages was normal in PB cRel 2/2 engraftment but not in NFjB2 2/2 (CD45.2) (Supporting Information Fig. S4 ). These results suggest that defects in the NIK-p100/p52 pathway but not in NIK-cRel pathway result in HSC dysfunction under proliferative stress conditions. Proliferation defect of NFjB2 hematopoietic stem/progenitor cells was also confirmed by the recovery of PB leukocyte counts after 5-FU treatment (Fig. 6C) . Finally, we further confirmed a delayed cell-cycle progression in response to cytokine stimulation in NFjB2 2/2 cells, by Lin2
CFSE labeling (Supporting Information Fig. S5A ). We observed a similar behavior between WT and cRel 2/2 cells, a complete delayed in NIK aly/aly cells, and a minor delay for NFjB2 2/2 cells in the dilution of CFSE (Supporting Information Fig. S5A ). 
STEM CELLS
As shown with NIK aly/aly mice, basal hematopoiesis was normal in NFjB2 2/2 and cRel 2/2 mice (Supporting Information  Fig. S6 ).
Gene Expression Profile Analysis
To explore the consequences of the defective NIK aly/aly protein in alternative NFKB signaling in HSCs in homeostatic conditions, we investigated the gene expression profile of highly purified fresh LSK cells isolated from WT and NIK aly/aly mice using whole mouse genome oligo microarrays. The rational was to know the transcriptional basal state of HSC that could counterpart for its response to stress.
Data analysis revealed that 301 genes were differentially expressed (fold change 1.5 and p-value < .05) from which 148 were upregulated (49.2%) and 153 (50.8%) downregulated (Supporting Information Table S1 ). Based on these results, there was no clear evidence for NIK aly/aly and WT mice, containing mSCF and hIL-11, were maintained during 14 days and total cell numbers and viability were analyzed weekly. *, p < .05. (B): Liquid cultures of freshly sorted LSK population from NIK aly/aly and WT mice were maintained during 14 days and total cell numbers and viability were analyzed weekly. **, p < .01. (C): Lin2 BM was labeled with CSFE and cultured in presence of cytokines. CSFE dilution was analyzed several days after culture started (above). An estimation of rounds of cell division at day 2 is shown (down-left). Apoptotic cells (Annexin V1) in in vitro culture of NIK aly/aly and WT Lin2 BM cells at days 2 and 5 after culture initiation (down-right). *, p < .05. Abbreviations: LSK, Lin being neither an overall transcriptional inductor nor a repressor. We specifically focused on genes associated to cell cycle, cell death, and cell proliferation, key processes in the assays we have previously described. As shown in Table 1 , genes with a known positive role in cell proliferation were mainly downregulated. However, genes promoting cell cycle arrest were also downregulated in NIK aly/aly cells. In the same manner, genes with either positive or negative roles in cell death were similarly represented in number in the list of genes differentially regulated by NIK.
Among these 301 genes, up to 12 have been previously described as direct or indirect NFjB transcriptional targets (http://www.bu.edu/nf-kb/gene-resources/target-genes/). Interestingly, a search for putative binding sites on the regulatory regions of the 153 downregulated transcripts revealed that 146 (95.4%) of them beared at least one target site for any of the NFjB-transcription factor family members (Supporting Information Table S3 ).
We then challenged these altered genes in an IPA pathway analysis restricted to those pathways that had been previously implicated in HSC. Supporting Information Figure S7 shows a comprehensive list of statistically significant altered pathways. No classic pathways related to the HSC fate such as BMP/TGFb, Wnt, or HOX transcription factors family among others were found. Pathways such as Retinoic Acid Receptor (RAR) activation (p-value .0012), production of nitric oxide, and reactive oxygen species in macrophages (p-value .0012), involved in Reactive Oxigen Species (ROS) regulation, appeared as the most significantly altered ones. Regarding NIK deficiency, pathways related to the function of NIK in the immune system such as IL-12 signaling and production in macrophages (p-value .0081), role of osteoblasts, osteoclasts, and chondrocytes in rheumatoid arthritis (p-value .0234), and Lymphotoxin b receptor signaling (p-value .038) were also significantly altered.
DISCUSSION
In this study, we show that NIK has a role in the function of hematopoietic stem/progenitor cells under stress, but seems dispensable under homeostatic conditions. Of the various downstream pathways that NIK may activate [18, 49, 50] , the NIK-p100/p52 pathway seems to be responsible for this function. NIK inactivation did not affect the numbers and proportions of stem/progenitor cell populations in BM in steadystate hematopoiesis, nor did it cause disturbances in mature cell numbers in PB (except for the reported defects in B cells) (Supporting Information Fig. S1 ). However, NIK-inactive HSCs had an impaired response to stressors such as supraphysiological levels of cytokines, myeloablative chemotherapy, or upon hematopoietic transplantation (Figs. 2, 4, 5) .
The NIK aly/aly mice used in this work bear a point mutation in the Nik gene [51] , which renders the kinase unable to bind IKKa and P100 and so, p100 is not processed [52] . NIK aly/aly mice, as well as NIK 2/2 mice [27] , have been used to study the role of NIK mainly in the immune system, since these animals have defects on lymphoid organogenesis and immune regulation [22, 23] . Some of these studies have shown both an intrinsic defect and also an important role of NIK in the stromal microenvironment of organs of the immune system (thymus, spleen, and lymph nodes), which negatively affected the function of NIK aly/aly immune cells. Accordingly, marrow stromal cultures initiated with total BM cells from NIK aly/aly mice have defects in supporting WT HSCs (our unpublished data). In this study, the transfer of NIK aly/aly HSCs into the WT microenvironment of recipients allowed us to address the role of NIK in HSCs independently of its role on the BM environment. NIK aly/aly HSCs engrafted in WT BM did not improve their functional capacities, underscoring an intrinsic role of NIK in HSCs, as shown in two different experiments. NIK aly/aly HSCs placed on a WT BM did not respond as efficiently as control HSCs to 5-FU (Fig. 4) nor did it engraft as robustly in a competitive repopulation assay ( Fig. 2A, 2E ). In fact, 5 months after the first transplant, the numbers of LSK BM cells were lower in the mice recipients of NIK aly/aly HSCs compared to those of mice transplanted with WT HSCs (Fig. 2D) .
In vitro cultures showed that upon stimulation, NIK aly/aly
HSCs compartment, LSK, and the more heterogeneous Lin2 population required a longer time to undergo rounds of cell divisions (Fig. 5B, left) , plus they underwent apoptosis at higher rates than WT HSCs (Fig. 5B, right) . The differences in apoptosis were more important early after the stimuli (Fig.  5B , right), in accordance with our previous results on activated T lymphocytes [21] . As a result of these combined 
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defects (early apoptosis and permanent impairment of proliferation), NIK aly/aly HSCs did not perform successfully in in vivo competitive repopulation transplants, nor regenerated hematopoiesis after 5-FU as fast as control WT HSCs.
Under 5-FU induced stress, the cycling status of LSK cells from NIK aly/aly was delayed compared to WT mice, as reflected by a higher percentage of cells in G0 at days 2 and 6 after treatment (Fig. 4C) , and lower proportion of actively cycling cells. The role of NIK in apoptosis after stress was shown by the increased proportion of living cells after 5-FU treatment in the WT versus NIK aly/aly (Fig. 4D ), 1.2-fold increase at day 2 and 2.5-fold at day 6. In accordance with in vitro cultures results, here we found that the day when LSK more actively proliferated (day 6, cell cycle analysis) was the moment when higher apoptosis was detected, likely due to higher sensitivity to activation induced cell death in NIK aly/aly LSK HSC. The similar total numbers of LSK at days 2 and 6 post-5-FU likely reflected a balance between the higher apoptosis of activated cells and the higher proportions of quiescent LSK HSCs. An additional consequence of the delayed cell cycle progression of the NIK aly/aly LSK cell population was their kinetics in BM after 5-FU. While day 2 values of LSK from NIK aly/aly were comparable to those at steady-state (compare to Fig. 1B) , a faster increase from basal levels was detected in the LSK proportions of WT mice. This increase was maintained at day 6 among LSK WT but proportions of NIK aly/aly LSK almost doubled at day 6, probably reflecting the higher percentages of quiescent LSK at day 2. It is well known that NFjB is involved in survival/antiapoptosis through proteins such as FLICE inhibitory protein, cIAP, surviving, Bcl-2, and Bcl-XL, and regulates the expression of genes related to cell growth, proliferation, differentiation, immune response, and inflammation [53] . We and others previously showed that NIK-deficient T lymphocytes were not able to generate GVHD because of high rates of apoptosis [21, 25] . Jin et al. described that NIK 2/2 mice (and NIK 2/2 T cell-transferred Rag2 2/2 mice) were resistant to EAE induction by Myelin Oligodendrocyte Glycoproteine (MOG) immunization, mainly because their T lymphocytes have limited proliferative capacity and Th17 differentiation [26] . Our results suggest that the loss of NIK negatively affects HSCs whenever they need to deal with stress. The fact that we found the major disturbances in HSCs function after stress and not under physiological conditions may suggest that the intensity of the signal should be important, as stress signals for HSCs during steady-state hematopoiesis should be milder than those during during hematopoietic reconstitution, that is, BM transplantation or administration of 5-FU. The absence of a fully functional NIK protein resulted in a delay in the duration of the cell cycle (Fig. 4C , 5B, left) and in apoptosis (Fig. 4D , 5B, right) when coping with stress. We cannot rule out the possibility that NIK aly/aly
HSCs may accumulate defects during steady state that only manifest under protracted stresses. We found comparable defects when using NIK aly/aly HSCs and NFjb2 2/2 HSCs (Fig. 6B) . These results underscore the role of the NIK-p100/p52 activation pathway in HSCs. There are two main pathways for NFjB activation. Canonical or classic pathway activation is rapid and transient and acts independently of protein synthesis. Noncanonical or alternative pathway is slower but persistent, and depends on de novo protein synthesis [50, 54, 55] . Noncanonical pathway regulates lymphoid organogenesis, B-cell survival and maturation, dendritic cell activation, and bone metabolism. Little is known about the role of the alternative pathway in HSC function. Zhao et al. [37] analyzed the HSC function in NFjb2 In our models, NIK aly/aly mice did not present significant differences in HSC subpopulations nor in the cell cycle status in basal conditions (Fig. 1) , and the transfer into a WT BM did not recover the functional capacities of HSCs (Figs. 2, 4 ). The differences found between our experiments and those of Zhao et al. may be related to the different KO molecules the NIK protein should be active in the double KO model, suggesting that in HSCs, NIK may also signal through mediators other than p100-p52-Relb.
The number of NIK regulated genes in our gene expression analysis was low if we compare it with published data (Supporting Information Fig. S7 and Supporting Information Table S1 ). One possible explanation is that NIK and genes of the alternative NFjB pathway are expressed at higher levels in lymphoid tissues compared to LSK HSCs. However, some of the genes identified in our study have already been found in other cellular systems, validating the significance of our work (Supporting Information Table S2 ) [56] [57] [58] [59] . The results from the array study supported the findings obtained in the functional assays shown in this work. The downregulation in the expression levels of genes that have a positive role in cell proliferation combined with the downregulation in the expression levels of genes involved in cell cycle arrest (Table  1) in resting NIK aly/aly HSCs suggest that these stem cells are not impaired for activating the cell cycle machinery but they are not fully equipped to actively respond to proliferative signals. In accordance with this, we did not find any significant difference in the distribution of HSCs along the different phases of the cell cycle in steady-state (Fig. 1C) but did find a delay on CFSE dilution in in vitro experiments. Regarding the different levels of apoptosis found in Figure 5B , basal expression levels of apoptosis-related genes were not affected by the NIK aly/aly mutation. This suggests that apoptosis is related to activation of HSC in these cells, as we have previously shown during T-cell activation [21] . The results of our analysis revealed a potential role for pathways (in Supporting Information Fig. S7 ) already related with HSC survival, that is, ROS metabolism [9] .
Cells from the immune system and from nonhematopoietic tissues produce cytokines during infections or stress that activate HSC through innate immune signaling pathways. Conversely, HSC can respond to Toll-Like receptors (TLR) stimulation [60, 61] leading to an increased myeloid cell production and NFjB has been implicated in this response. It is temptative to speculate that a deficit in NFjB signaling in this context (as shown in our models) would result in an impaired response to the stress. It is interesting to note that molecules related with TLR signaling came up in our gene expression analysis, such as Tlr6, Irf8, Il4, some TNF receptors (Tnfrsf11b), or TGF-b signaling (Smad5), all of them genes that regulate proliferation and differentiation of HSC.
CONCLUSIONS
In summary, our results suggest that NIK and the noncanonical NFjB pathway are needed for HSCs to respond to stressful conditions, while it could be dispensable during steady-state hematopoiesis. The inactivation of this kinase would be detrimental for the hematopoietic system in vivo, a strategy we initially contemplated in the allogeneic setting [21] .
